Communiqué de presse : ISTH : De nouvelles données sur ALTUVIIIO et le fitusiran confortent le leadership de Sanofi dans le traitement de...
Press Release: Sanofi and Biovac spearhead polio vaccine manufacturing capabilities in Africa Sanofi and Biovac spearhead polio vaccine...
Sanofi: Information concerning the total number of voting rights and shares – May 2024 Information concerning the total number of voting...
Press Release: ASCO: Sarclisa is first anti-CD38 to significantly improve progression-free survival in combination with VRd for newly diagnosed...
Communiqué de presse : Sanofi lance son plan mondial 2024 d’actionnariat salarié Sanofi lance son plan mondial 2024 d’actionnariat salarié...
Communiqué de presse : Le CHMP recommande l'approbation de Dupixent dans l'UE pour le traitement des patients atteints de BPCO Le...
Press Release: Update on FDA priority review of Dupixent for the treatment of COPD patients with type 2 inflammation Update on FDA priority...
Press Release: Sanofi completes acquisition of Inhibrx, Inc. Sanofi completes acquisition of Inhibrx, Inc. Paris, May 30, 2024. Sanofi...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.